First Trust Large Cap Growth Fund (FTC)
FTC to sue drug middlemen over prices of medications including insulin
The Federal Trade Commission is planning to sue three large U.S. health companies over their practices as middlemen who negotiate prices for medications such as insulin, a source familiar with the matter told CNBC. The suits are set to target the three biggest so-called pharmacy benefit managers, UnitedHealth Group's Optum Rx, CVS Health's Caremark and Cigna's Express Scripts, which are all owned by or connected to health insurers.
Tempur Sealy mattress takeover hit by FTC lawsuit
The $4 billion takeover by bedding group Tempur Sealy International (NYSE:TPX) of Mattress Firm Group Inc is facing a legal challenge from the US antitrust agency. Overnight, the Federal Trade Commission took the deal to federal court to block the combination of the largest US mattress maker with the biggest bedding retailer.
Gig-work company Arise settles with FTC for $7 million over ‘false promises' of pay
NEW YORK — The Federal Trade Commission is taking action against a gig-work company, saying it misled people about the money they could make on its platform.
FTC unanimously votes to block $4B Tempur Sealy, Mattress Firm merger
The commission said the acquisition could hike prices for consumers, take out competitors and cut jobs at rival mattress companies.
FTC sues to block $4B merger of mattress firms
The Federal Trade Commission voted to file a lawsuit to block the proposed $4 billion merger between Tempur Sealy and Mattress Firm over concerns about its competitive impact.
Teva's stock falls after report FTC has opened probe of patents
Teva Pharmaceuticals Industries Ltd.'s stock fell 2% Monday after a report said the Federal Trade Commission has opened an investigation into the Israeli generics company, citing its refusal to take down roughly two dozen patents for its asthma and COPD inhalers.
FTC starts probe into Teva about some products' patents, Washington Post reports
The U.S. Federal Trade Commission has opened an investigation into Teva Pharmaceutical over the company's refusal to take down about two dozen patents for its asthma and COPD inhalers, the Washington Post reported on Monday, citing agency documents.
3 Stocks that Might Benefit From the FTC-Adobe Lawsuit
The news of the U.S. government's allegations has shaken the financial sector. Adobe is at the center of a criticism storm from the Federal Trade Commission (FTC), which claims that the company concealed the cost of canceling its subscription plan.
FTC Alleges Adobe Deters Subscription Cancellations, Hides Early Termination Fee
The Federal Trade Commission (FTC) is taking action against Adobe and two of its executives, alleging that they deceived consumers by hiding an early termination fee on a subscription plan and making it difficult for customers to cancel their subscriptions.
Is First Trust Large Cap Growth AlphaDEX ETF (FTC) a Strong ETF Right Now?
Launched on 05/08/2007, the First Trust Large Cap Growth AlphaDEX ETF (FTC) is a smart beta exchange traded fund offering broad exposure to the Style Box - Large Cap Growth category of the market.
Music Publishers File FTC Complaint Against Spotify Claiming ‘Fraudulent' Practices
“Spotify has declared war on songwriters. Our response shall be all-encompassing.
Spotify Faces FTC Complaint From Music Publishers
Spotify is facing an FTC complaint from music publishers and songwriters over royalties. As Bloomberg News reported, the National Music Publishers' Association (NMPA) filed the complaint with the Federal Trade Commission (FTC) Wednesday (June 13), alleging that the streaming audio platform's decision to offer audiobooks to subscribers meant fewer royalty payments to songwriters.
